Soligenix
SNGX
#11028
Rank
S$6.64 M
Marketcap
S$0.28
Share price
-8.29%
Change (1 day)
-83.53%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -S$15.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$15.3 Million a decrease over its 2024 earnings that were of -S$12.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$15.01 Million-1.9%
2025 -S$15.3 Million26.72%
2024 -S$12.08 Million22.96%
2023 -S$9.82 Million-45.74%
2022 -S$18.1 Million11.88%
2021 -S$16.18 Million-32.37%
2020 -S$23.92 Million83.18%
2019 -S$13.06 Million11.57%
2018 -S$11.71 Million19.29%
2017 -S$9.81 Million33%
2016 -S$7.38 Million-19.7%
2015 -S$9.19 Million5.16%
2014 -S$8.74 Million
2010 -S$9.86 Million26.12%
2009 -S$7.82 Million75.1%
2008 -S$4.47 Million-45.38%
2007 -S$8.18 Million-22.84%
2006 -S$10.6 Million66.15%
2005 -S$6.38 Million-16.65%
2004 -S$7.65 Million13.28%
2003 -S$6.76 Million-11.88%
2002 -S$7.67 Million-59.44%
2001 -S$18.89 Million378.18%
2000 -S$3.96 Million-38.53%
1999 -S$6.43 Million-18.43%
1998 -S$7.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.17 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.99 B-59,636.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$10.05 B-66,642.75%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-S$23.45 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.94 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.58 B-10,558.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-S$3.56 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-S$0.26 Billion 1,562.71%๐Ÿ‡บ๐Ÿ‡ธ USA